Literature DB >> 21719645

Medical oncology: the long-awaited prize of recognition.

P G Casali.   

Abstract

Mesh：

Year:  2011        PMID： 21719645     DOI： 10.1093/annonc/mdr314

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  The American Society of Clinical Oncology's Efforts to Support Global Cancer Medicine.

Authors:  Gabriel N Hortobagyi; Nagi S El-Saghir; Tanja Cufer; Eduardo Cazap; Roselle de Guzman; Nicholas Anthony Othieno-Abinya; Jose Angel Sanchez; Doug Pyle
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

2.  Identification of differences in immunotherapy knowledge and practice patterns among oncologists from six European countries.

Authors:  Ivan Marques Borrello; Madeline Mag Schaffer; Elena Roehrl; Jessica Falco Marshall
Journal:  Mol Clin Oncol       Date:  2014-01-14

3.  The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe.

Authors:  Nicholas Pavlidis; Emilio Alba; Rossana Berardi; Jonas Bergh; Nagi El Saghir; Jacek Jassem; Michael Kosty; Roberto Ivan Lopez; Jean-Pierre Lotz; Pia Österlund; Gunta Purkalne; Christian Dittrich
Journal:  ESMO Open       Date:  2016-01-18

4.  Differences in the outcomes of adjuvant chemotherapy for colon cancer prescribed by physicians in different disciplines: a population-based study in Taiwan.

Authors:  Cheng-I Hsieh; Raymond Nien-Chen Kuo; Chun-Chieh Liang; Hsin-Yun Tsai; Kuo-Piao Chung
Journal:  BMJ Open       Date:  2018-12-18       Impact factor: 2.692

5.  Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey.

Authors:  T Cufer; M Kosty; P Osterlund; S Jezdic; D Pyle; A Awada; J Close; N El-Saghir; F Lordick; P Rutkowski; A Tfayli; H Wildiers
Journal:  ESMO Open       Date:  2021-09-16

6.  ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016.

Authors:  C Dittrich; M Kosty; S Jezdic; D Pyle; R Berardi; J Bergh; N El Saghir; J-P Lotz; P Österlund; N Pavlidis; G Purkalne
Journal:  Ann Oncol       Date:  2016-08       Impact factor: 32.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.